Vacc-iNTS project

[Vacc-iNTS project @VacciNTS]

🎯Vacc‑iNTS 2026 Annual Meeting marked the successful end of this H2020 project. Coordinated by the Sclavo Vaccines Association, the consortium advanced also an iNTS vaccine through a Phase I trial in Europe and Kenya and key studies that deepened understanding of the disease.

[Vacc-iNTS project @VacciNTS]

Do you remember when you joined X? I do! #MyXAnniversary

[Vacc-iNTS project @VacciNTS]

🚨 Exciting update from Siena, Italy! 🚨

👉🏻The Vacc-iNTS Consortium is gathering today for the 2025 annual meeting to discuss progress on the development of a novel vaccine against #iNTS. Recent results from the various work packages will be presented 🎯

[Melita Gordon @MelitaGordon5]

Team Malawi in our Salmonella-happy-place, enjoying hanging with our favourite #Salmonella pals from all over the world in Rwanda. Exciting progress being reported, and even more possibilities ahead for tackling #iNTS and #typhoid. @VacciNTS @PreventTyphoid #VaccinesWork

[Vacc-iNTS project @VacciNTS]

👉https://t.co/Ya6szKgVD2

[International Union of Microbiological Societies @IUMSmicrobio]

🎉 The time has come 🎉
We are more than excited to invite you to #IUMS2024: ‘Microbiological adaptation in times of ecological disturbance and disruption’ 🦠

💚 Save The Date 💚
📆 23-25 October 2024

➡️ Subscribe to be the first to learn all updates: https://t.co/zcwtjs2SoR

[Vacc-iNTS project @VacciNTS]

⌛️Final few hours to register for the VSV-EBOPLUS Open Conference on “Systems analysis of adult and pediatric responses to the VSV-ZEBOV Ebola vaccine” virtually happening at 3:00-6:00 p.m. CEST🎯
Info to sign up ➡️ https://t.co/cxAUnxSjZL

[Vacc-iNTS project @VacciNTS]

Today the Vacc-iNTS Consortium is meeting in Siena (Italy) for the 2023 annual meeting to discuss the progress on the activities for the advancement of the development on a novel vaccine against #iNTS and recent results of the different work packages will be presented.

[Oxford Vaccine Group @OxfordVacGroup]

Help us prevent blood poisoning in children under 5 years of age in sub-Saharan Africa.

𝐓𝐡𝐞 𝐒𝐀𝐋𝐕𝐎 𝐓𝐫𝐢𝐚𝐥: 𝐓𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐞𝐯𝐞𝐫 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐟𝐨𝐫 𝐢𝐍𝐓𝐒

Join our study and help us make a difference to millions.🔻

https://t.co/IRSGQqRqng

@VacciNTS

[Oxford Vaccine Group @OxfordVacGroup]

Help us prevent a neglected infectious disease.

We will provide reimbursement, up to a maximum of £585, for your time, inconvenience and travel. The total study participation time is 12 months.

Join our study and help us make a difference to millions.🔻

@VacciNTS

[GSK @GSK]

#News for #investors & #media Invasive non-typhoidal Salmonella disease can be life-threatening for children in Africa and a key driver of #AMR. We're using our GMMA technology and partnering with @UniofOxford @OxfordVacGroup @VacciNTS to explore a potential candidate vaccine.

[Department of Paediatrics @OxPaediatrics]

Could you help investigate a new vaccine?

You are invited to take part in a study to investigate an invasive non-Typhoid Salmonella (iNTS) disease.

The study is being run by the @OxfordVacGroup & would not be possible without @VacciNTS

➡️https://t.co/IMS8TtuPyV

[Vacc-iNTS project @VacciNTS]

👉Do you want to learn more about complications and mortality of the iNTS disease?
🌍Proud to share this review!

This study received funding from the European Union's Horizon 2020 research and innovation program (grant agreement No 815439).
#vaccintsproject #openaccess #H2020

[The Lancet Infectious Diseases @TheLancetInfDis]

New research Article: Complications and mortality of non-typhoidal #salmonella invasive disease: a global systematic review and meta-analysis https://t.co/vfmEbppAfq

[Take on Typhoid @PreventTyphoid]

The 12th International Conference on #Typhoid & Other Invasive Salmonelloses is going virtual on Dec 6-8, 2021! Learn more + register here: https://t.co/KI1ZDV9B0G #Typhoid2021

[Vacc-iNTS project @VacciNTS]

🗓️The Vacc-iNTS 2021 Annual Meeting will take place today and tomorrow. 🌍Happy to meet all Partners!

#vaccintsannualmeeting
#H2020

[Vacc-iNTS project @VacciNTS]

Registration is still open for the 10th EDCTP Forum on Equality in Research for Health!

[EDCTP @EDCTP]

One week left until the Tenth #EDCTPForum With over 1300 registered participants, 223 poster presentations and a three-day programme full of sessions, symposia and workshops we look forward to welcoming you!

More info & register: https://t.co/ymL77nWnzl

[Melita Gordon @MelitaGordon5]

Yep, true story. Invasive non-typhoidal Salmonella remains an unrecognised killer .... But iNTS, we see you & we're comin' after ya ... vaccines are on the horizon and we're gearing up #Malawi @VacciNTS @MlwTrust

[Vacc-iNTS project @VacciNTS]

Today is the day: very happy to virtually meet all Partners at the first Vacc-iNTS annual meeting!

[Master in Vaccinology and Drug Development @InVaccinology]

🆕 Applications now open‼️‼️

We are pleased to announce that Master in Vaccinology💉 and Drug Development 💊academic year 2020-2021 is now #open for #applications up to September 30, 2020 at 11:59PM italian time.

✅ https://t.co/TFbiTal7lW
@unisiena

[Vacc-iNTS project @VacciNTS]

ECCMID 2021 New dates: the 31st ECCMID will take place from Friday, 9 July to Monday, 12 July 2021 in Vienna, Austria.

[ESCMID @ESCMID]

It is our pleasure to invite you to the 31st ECCMID, which will take place from Friday, 9 July – Monday, 12 July 2021. We are very much looking forward to holding ECCMID next summer, in the sunny city of Vienna, Austria 🇦🇹